Ad www.ProStocks.com
FREE Account Opening + No Clearing Fees + Rs 999 API Access
|
|
| Issue Open | Jun 16, 2017 |
| Issue Close | Jun 20, 2017 |
| IPO Price | ₹603 |
| Face Value | ₹1 |
| IPO Size | ₹1,741.16 Cr |
| Listing At | BSE, NSE |
| IPO Lot Size | 24 |
Mon, 17 Jan 2022 08:18:00 GMT
Several high-profile funding bankers opted to remain out of the dealmaking enterprise to affix extra strategic roles within the final 12-18 months, despite report M&A volumes and a frenzy IPO year ...
Sun, 16 Jan 2022 22:57:23 GMT
During his stint at KPMG India, Vikram Hosangady held key positions like Head of Deal Advisory (Europe, Middle East, Africa and India) & Head of Private Equity. In October, 2021, Yezdi Nagporewalla ...
Tue, 28 Dec 2021 21:33:00 GMT
Eris Lifesciences share price gained over 6 percent on December 218 after Motilal Oswal initiated coverage on the stock with a ‘buy’ call. The domestic research firm has initiated coverage on ...
Mon, 06 Dec 2021 01:24:00 GMT
The company stated that “Eris MJ Biopharm” has been created to leverage the significant market opportunity in Human Insulin, Analogues and GLP1 Agonists. Eris Lifesciences has announced its ...
Sun, 05 Dec 2021 20:46:00 GMT
Shares of Eris Lifesciences ERIS.NS jumped nearly 10% in early trade as the company marked its entry into the insulin segment with a joint venture with MJ Biopharm. Broader Asian share markets ...
Mon, 03 Jan 2022 11:00:00 GMT
Initiate coverage with a Buy rating. We initiate coverage on Eris Lifesciences (ERIS) with a Buy rating and a target price of Rs 870. In just 14 years (founded in CY07), ERIS has built a pure-play ...
Wed, 15 Dec 2021 10:30:00 GMT
Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. supriya lifesciences share price Blogs, Comments and Archive News on Economictimes.com ...
Fri, 07 Jan 2022 13:00:00 GMT
But we were also cautious, telling investors the Metro Brands IPO valuation provides little margin of safety ... from smaller competitors hit badly by the pandemic. We looked at Eris Lifesciences’ ...
Mon, 10 Jan 2022 03:53:00 GMT
Indoco Remedies Ltd, Eris Lifesciences Ltd, GlaxoSmithKline Pharmaceuticals Limited, Dr Reddy’s Laboratories Ltd also saw their secondary sales growth ahead of IPM.
Tue, 28 Dec 2021 12:18:00 GMT
Sundaram Clayton Ltd notched up volume of 1.94 lakh shares by 10:50 IST on BSE, a 323.21 fold spurt over two-week average daily volume of 599 shares Indraprastha Gas Ltd, ERIS Lifesciences Ltd ...
Wed, 29 Dec 2021 04:00:00 GMT
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily ...
Eris Lifesciences IPO Listing Date
› Listing Date: Thursday, June 29, 2017
› BSE Script Code: 540596
› NSE Symbol: ERIS
› Listing In: ‘B’ Group of Securities
› ISIN: INE406M01024
› Issue Price: Rs 603 Per Equity Share
› Face Value: Rs 1 Per Equity Share
Eris Lifesciences IPO allotment stautus is now available online.
Eris Lifesciences Limited IPO to open on Jun 16, 2017 and close for subscription on Jun 20, 2017. The price band for the issue has been fixed at Rs 600 at lower level and Rs 603 at upper level. The equity shares of the company to be list at BSE and NSE.
Eris Lifesciences Ltd is entering in the capital market with an Offer for Sale of 28,875,000 Equity Shares of Rs 1. The price band for the issue has been fixed at Rs 600 at lower level and Rs 603 at upper level.
Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.
The issue opens on Jun 16, 2017 and closes for subscription on Jun 20, 2017. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Eris Lifesciences IPO is proposed to open on Jun 16, 2017. The IPO application ends on Jun 20, 2017.
Retail investors can apply in the retail or non-institutional investor category from Jun 16, 2017 to Jun 20, 2017. The Eris Lifesciences IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Eris Lifesciences IPO will open for subscription on Jun 16, 2017. The public issue will close on Jun 20, 2017.
Useful Articles
